NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Spoke to Robert Willoughby at POM Law at length. Said I was interested in joining the law suit - if they were suing The Street and AF. Of course, to which he replied they wouldn't be doing that. Anyhow, I asked him if he'd ever lost anyone to cancer - to which he replied his dad. I said NWBO was working on a product with a potential to kill off this deadly disease (Direct) and told him about the results of the animal results with the initial direct study. I then told him about the latest results of Direct in people. He asked if I would send him the link to that information. I also told him that Adam regularly bashes NWBO and that the doctor he interviewed isn't even a part of the trial.

I got the feeling he knew very little about NWBO and that the law firm had just immediately put out a pr in an attempt to grab any discontented shareholders in the event that NWBO had done something wrong - which they haven't.

Here's my letter:

Hi Robert -

Thanks for taking the time to talk with me about NWBO today. I’m sorry to hear about your dad and that you lost him to cancer. It’s unfortunate that almost all of us have been effected at some time or another by the devastating nature of this horrible disease.

As I mentioned, Direct’s initial trial was done on mice and found the following results:

When DCVax-Direct was administered in pre-clinical animal studies, existing tumors regressed. Importantly, the tumors that regressed included not only tumors that were injected with DCVax-Direct but also tumors on the opposite side of the animal's body which were not injected, indicating a systemic immune response. Further, when the animals were subsequently challenged (i.e., injected) with cancer cells, the animals did not re-develop cancer, indicating immune memory. Notably, the company's proprietary activation step for the dendritic cells appeared to be essential for these results.

Link:
www.dddmag.com/news/2012/09/fda-approves-northwest-trial

Here is the latest update on Direct and it’s effect on inoperable tumors - this is the trial Adam is referencing.
Link:
http://finance.yahoo.com/news/dcvax-direct-trial-indicates-further-121500060.html


The other notable product by NWBO is DCVax L - which attacks Glioblastoma Multiforme - a deadly brain cancer where the patient averages 14 months of life once diagnosed - with surgery, with radiation, and with chemo.

DCVax-L has shown an average of 3 years of life when added to the standard of care treatment for this disease in the Phase II trials. They are in phase III trials now and Germany has decided to allow their citizens access to the drug - and they will pay for it.

Link:

https://news.yahoo.com/exclusive-germany-permits-sale-northwest-bio-brain-cancer-114955415--finance.html

Note: this is Adam Feuerstein’s SIXTEENTH attack on NWBO THIS YEAR. He has a negative agenda against NWBO because he supports their competition AstraZeneca and Celldex. This doctor spoke with an investment blogger whose agenda is to help those who have shorted 6 million shares of stock against this company get out of those positions.

I’m not a clinical expert in immunotherapy but I don’t understand Adam Feuerstein’s obsession to strangle this potentially significant therapy.

Thank you for your consideration. You indicated that you would pass on to the appropriate people that if your company decides to withdraw from any pursuit of legal action of NWBO, that they consider releasing a press release to that effect.

If I got any of the facts wrong, sue me.